Literature DB >> 5056660

Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion.

G H Williams, M L Tuck, L I Rose, R G Dluhy, R H Underwood.   

Abstract

The peripheral plasma levels of aldosterone, renin activity, potassium, sodium, corticosterone, and cortisol were measured in six normal subjects four times daily-10 a.m., 2 p.m., 5 p.m., 11 p.m.-on 3 consecutive days. A constant daytime activity program was maintained throughout the study. After 5 days on a 10 mEq sodium/100 mEq potassium isocaloric intake, the mean upright 10 a.m. plasma renin activity was 1773+/-186 ng/100 ml per 3 hr and the mean plasma aldosterone, 81+/-14 ng/100 ml. These two parameters fell continuously throughout the day parallel to the fall in plasma cortisol and corticosterone. In response to 2 liters of normal saline infused from 10 a.m. to 2 p.m. on 2 consecutive days, plasma aldosterone levels fell significantly to 13+/-5 ng/100 ml at 2 p.m. after the 1st day's infusion and to 6+/-1 ng/100 ml at 2 p.m. after the 2nd. Plasma renin activity demonstrated a parallel fall to 368+/-63 ng/100 ml per 3 hr and 189+/-27 ng/100 ml per 3 hr at 2 p.m. on the 1st and 2nd days, respectively. There was no significant alteration in plasma levels of cortisol, corticosterone, potassium, or sodium on the 2 days of sodium loading in comparison with the control day. In an additional study, five normal supine subjects received 500 ml saline/hr for 6 hr. As in the 2 day study, plasma aldosterone and renin activity had parallel decrements at 1, 2, 4, and 6 hr after the start of the saline infusion. From these studies, it is concluded that plasma renin activity is the dominant factor controlling plasma aldosterone when sodium-depleted normal subjects are acutely repleted.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5056660      PMCID: PMC332963          DOI: 10.1172/JCI107082

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The regulation of aldosterone secretion in man: the role of fluid volume.

Authors:  J K BARBER; F C BARTTER; C DELEA; L E DUNCAN; G W LIDDLE
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

2.  Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension.

Authors:  G H Williams; L I Rose; R G Dluhy; D McCaughn; P I Jagger; R B Hickler; D P Lauler
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

3.  Circulating angiotensin-II and aldosterone levels during dietary sodium restriction.

Authors:  J B Best; J P Coghlan; J H Bett; E J Cran; B A Scoggins
Journal:  Lancet       Date:  1971-12-18       Impact factor: 79.321

4.  Saline suppression of plasma aldosterone in hypertension.

Authors:  D C Kem; M H Weinberger; D M Mayes; C A Nugent
Journal:  Arch Intern Med       Date:  1971-09

5.  The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis.

Authors:  R H Underwood; G H Williams
Journal:  J Lab Clin Med       Date:  1972-05

6.  The natriuresis of fasting: relationship to changes in plasma renin and plasma aldosterone concentrations.

Authors:  R H Chinn; J J Brown; R Fraser; S M Heron; A F Lever; L Murchison; J I Robertson
Journal:  Clin Sci       Date:  1970-09       Impact factor: 6.124

7.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

8.  The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.

Authors:  H R Brunner; L Baer; J E Sealey; J G Ledingham; J H Laragh
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

9.  Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.

Authors:  R D Collins; M H Weinberger; A J Dowdy; G W Nokes; C M Gonzales; J A Luetscher
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

10.  Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.

Authors:  G H Williams; J P Cain; R G Dluhy; R H Underwood
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  9 in total

Review 1.  Minireview: aldosterone biosynthesis: electrically gated for our protection.

Authors:  Nick A Guagliardo; Junlan Yao; Changlong Hu; Paula Q Barrett
Journal:  Endocrinology       Date:  2012-06-11       Impact factor: 4.736

2.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.

Authors:  M L Tuck; R G Dluhy; G H Williams
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

4.  A comparison of the segmental analysis of sodium reabsorption during Ringer's and hyperoncotic albumin infusion in the rat.

Authors:  J H Stein; R W Osgood; S Boonjarern; T F Ferris
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

5.  Feedforward activation of endothelial ENaC by high sodium.

Authors:  Stefanie Korte; Alexandra S Sträter; Verena Drüppel; Hans Oberleithner; Pia Jeggle; Claudia Grossmann; Manfred Fobker; Jerzy-Roch Nofer; Eva Brand; Kristina Kusche-Vihrog
Journal:  FASEB J       Date:  2014-05-27       Impact factor: 5.191

6.  Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.

Authors:  P Y Wong; R C Talamo; G H Williams; R W Colman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

7.  A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone.

Authors:  Erfan Maddah; K Melissa Hallow
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-07-01       Impact factor: 2.410

8.  Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.

Authors:  Bryan Williams; Thomas M MacDonald; Steve V Morant; David J Webb; Peter Sever; Gordon T McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Sandosh Padmanabhan; Isla S Mackenzie; Jackie Salsbury; Morris J Brown
Journal:  Lancet Diabetes Endocrinol       Date:  2018-04-11       Impact factor: 32.069

Review 9.  Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.

Authors:  Nada El Ghorayeb; Isabelle Bourdeau; André Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-27       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.